Rennova Health, Inc. (OTCMKTS:RNVA) announced its earnings results on Monday. The company reported ($10.59) earnings per share for the quarter, Bloomberg Earnings reports.
Rennova Health (OTCMKTS:RNVA) traded down $0.01 during trading on Tuesday, hitting $0.13. The company had a trading volume of 572,104 shares, compared to its average volume of 474,591. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of -0.23. Rennova Health has a 12-month low of $0.11 and a 12-month high of $103.50.
About Rennova Health
Rennova Health, Inc (Rennova), formerly CollabRx, Inc, is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers.
Receive News & Ratings for Rennova Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rennova Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.